Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11033-021-06701-6.pdf
Reference42 articles.
1. Huang L, Xu AM (2017) SET and MYND domain containing protein 3 in cancer. Am J Transl Res 9(1):1–14
2. Yi X, Jiang XJ, Fang ZM (2019) Histone methyltransferase SMYD2: ubiquitous regulator of disease. Clin Epigenetics 11(1):112. https://doi.org/10.1186/s13148-019-0711-4
3. Fabini E, Manoni E, Ferroni C, Del RA, Bartolini M (2019) Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: Current trends. Future Med Chem 11(8):901–921. https://doi.org/10.4155/fmc-2018-0380
4. Rajajeyabalachandran G, Kumar S, Murugesan T et al (2017) Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents. Expert Opin Ther Targets 21(2):145–157. https://doi.org/10.1080/14728222.2017.1272580
5. Bottino C, Peserico A, Simone C, Caretti G (2020) SMYD3: An oncogenic driver targeting epigenetic regulation and signaling pathways. Cancers (Basel) 12(1):142. https://doi.org/10.3390/cancers12010142
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Epigenetic upregulation of MNAT1 by SMYD2 is linked to PI3K/AKT activation and tumorigenesis of pancreatic adenocarcinoma;HISTOL HISTOPATHOL;2024
2. Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription;Clinical Epigenetics;2023-05-26
3. Protein Lysine Methyltransferase SMYD2: A Promising Small Molecule Target for Cancer Therapy;Journal of Medicinal Chemistry;2022-08-01
4. Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2;Cancers;2022-07-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3